No CrossRef data available.
Article contents
Clinical audit on nice guidance on anticholinesterases in a memory clinic
Published online by Cambridge University Press: 16 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction
The National Institute for Clinical Excellence (NICE) has laid down certain guidelines for prescribing Anti-cholinesterases in patients with dementia. Keeping in mind the NICE guidance, an audit was conducted to see whether these were followed.
Aims and objectives
To ascertain the level of compliance to the NICE guidance and ensure they are adhered to.
Method
The data was collected from patients attending the memory clinic at Park Royal Centre for Mental Health in Central London over a six month period. Sixteen patients were randomly selected for this audit. The baseline MMSE score was recorded and also the medication prescribed.
Results
The baseline MMSE score in all the 16 (100%) patients was above the recommended score of 12.
The MMSE score was done in 12(75%) patients during follow up at 4–6 months.
Of the 12 available MMSE scores at follow up, none were below 12 and hence continued treatment.
In 2 (12.5%) patients there was an improvement, in 6 (37.5%) patients there was a fall and in 4 (25%) patients there was no change in the MMSE score at follow up.
Conclusion
It was found that the NICE guidance was followed in most (75%) patients.
- Type
- P02-233
- Information
- European Psychiatry , Volume 26 , Issue S2: Abstracts of the 19th European Congress of Psychiatry , March 2011 , pp. 829
- Copyright
- Copyright © European Psychiatric Association 2011
You have
Access
Comments
No Comments have been published for this article.